AI Medical Imaging Software Market
Every Market-Reports.com study delivers in-depth market sizing, growth forecasts, competitive intelligence, segmentation analysis, and regional insights — built from company filings, government statistics and trade data, and structured for confident strategic decision-making. Request a free report preview to see its scope, chapters and methodology before you buy.
Market Snapshot
2025 Market Size
US$ 2.7 billion
Estimated Base Value
2035 Forecast
US$ 12.4 billion
Projected Market Value
CAGR 2026–2035
16.5%
Compound Annual Growth
Largest Segment
Radiology AI Software
Fastest Growing Segment
Electric Commercial Vehicles
Leading Region
North America
Fastest Growing Region
Asia Pacific
Top Country
United States
By Market Share
Largest market
Key Players
Aidoc
Emerging Players
Annalise.ai, Gleamer
AI Medical Imaging Software Market Overview
The AI Medical Imaging Software market encompasses advanced software solutions that utilize artificial intelligence, including machine learning and deep learning algorithms, to analyze medical images from modalities such as X-ray, MRI, CT, ultrasound, and PET. These solutions are designed to enhance diagnostic accuracy, automate image interpretation, quantify disease progression, and assist clinicians in treatment planning across various medical specialties. Key purchasers of this software include hospitals, diagnostic imaging centers, research institutions, and pharmaceutical companies seeking to improve efficiency and precision in clinical workflows.
The market is estimated at $2.7 Bn in 2025 and is forecast to reach $12.4 Bn in 2035, growing at a CAGR of 16.5% from 2025 to 2035. Demand is primarily driven by the increasing need for early and accurate disease diagnosis and the growing global shortage of skilled radiologists. However, stringent regulatory approval processes and high implementation costs present challenges to market expansion and widespread adoption, particularly for smaller healthcare providers.
The market is segmented by Type (Radiology AI Software, Pathology AI Software, Cardiology AI Software, etc.), Application (Disease Detection and Diagnosis, Prognosis and Risk Assessment, Treatment Planning and Guidance, etc.), Technology (Deep Learning, Machine Learning, etc.), End-User (Hospitals, Diagnostic Imaging Centers, etc.), Deployment (On-Premise, Cloud-Based, Hybrid), and Functionality (Image Segmentation and Registration, Feature Extraction and Quantification, etc.). Geographically, the market is served across North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Leading companies include Aidoc, Viz.ai, Lunit, Qure.ai, PathAI, PAIGE, Nanox AI, Brainomix, HeartFlow, Arterys, Volpara Health Technologies, and Riverain Technologies. The full report provides a detailed analysis of these segments, drivers, restraints, and regional dynamics.
Market Definition & Overview
The AI Medical Imaging Software market comprises advanced software solutions leveraging artificial intelligence, including machine learning and deep learning algorithms, to analyze medical images generated by modalities such as X-ray, MRI, CT, ultrasound, and PET. This market focuses on applications that enhance diagnostic accuracy, automate image interpretation, quantify disease progression, and assist clinicians in treatment planning across various medical specialties. It encompasses tools designed to detect anomalies, segment organs, identify biomarkers, and predict patient outcomes, thereby improving efficiency and precision in clinical workflows within the medical devices and AI diagnostics industry.
Scope
- Global market coverage for AI medical imaging software.
- Focus on dedicated AI-powered software solutions for image analysis.
- Market analysis covering the period from 2025 to 2035.
Inclusions
- AI-driven software for analysis of CT, MRI, X-ray, ultrasound, and PET images.
- AI solutions for disease detection, quantification, and anomaly identification.
- Machine learning and deep learning algorithms specifically for medical image processing.
- AI software applications for treatment planning and predictive analytics in imaging.
- Cloud-based and on-premise AI medical imaging software platforms.
Exclusions
- Medical imaging hardware, such as CT scanners or MRI machines.
- Non-AI conventional image viewing software or Picture Archiving and Communication Systems (PACS).
- AI solutions for non-imaging medical applications, such as electronic health record analysis.
- General-purpose AI platforms not specifically tailored for medical imaging.
- Consulting or manual interpretation services by human radiologists.
Market Size Forecast
Executive Summary
• The AI Medical Imaging Software market is valued at $2.7 Bn in 2025 and is forecast to reach $12.4 Bn by 2035, reflecting a robust CAGR of 16.5% as demand accelerates across every major segment and region over the ten-year outlook.
• On-Premise leads the segment breakdown by current market share, underscoring where the bulk of near-term revenue and competitive activity within this market is concentrated today.
• North America commands the largest regional share at XX.X%, while Emerging Areas is expanding fastest at a XX.X% CAGR, signalling where future growth is shifting.
• United States remains the single largest country-level market at XX.X% of global share, anchoring overall demand within its home region throughout the forecast period.
• Major tech players are accelerating M&A, consolidating market share and driving an integrated platform approach, challenging smaller innovators to specialize or seek strategic partnerships for survival.
• Advanced algorithm development, coupled with expanding regulatory clarity and robust data sets, fuels a critical inflection point for widespread clinical adoption across diverse imaging modalities and therapeutic areas.
• Disparate reimbursement policies and varying data privacy regulations across key geographies significantly shape localized market entry strategies, favoring regional collaborations and tailored product localization for sustainable growth.
• Significant venture capital and strategic investments are increasingly targeting early-stage diagnostic AI, particularly solutions integrating seamlessly with existing PACS infrastructure and enterprise imaging ecosystems for accelerated deployment.
• The persistent challenge of clinical validation at scale, alongside ensuring ethical AI deployment and addressing physician workflow integration, remains paramount for achieving deep market penetration and long-term trust.
• Differentiation will increasingly hinge on demonstrated clinical efficacy, robust explainability features, and superior post-deployment support, moving beyond basic diagnostic assistance to predictive and personalized patient care pathways.
Key Market Takeaways
Critical findings and data points from this market research study.
Current Market Value
The AI Medical Imaging Software Market was valued at $2.7 billion in the base year, reflecting its established presence within medical diagnostics.
Future Market Projection
This market is projected for substantial growth, reaching an impressive $12.4 billion by the forecast year.
Robust Growth Outlook
The AI Medical Imaging Software Market is set to expand rapidly, demonstrating a strong Compound Annual Growth Rate (CAGR) of 16.5%.
Rapid Expansion Rate
From a base of $2.7 billion, the market's ascent to $12.4 billion is driven by a remarkable 16.5% CAGR, signifying rapid adoption and innovation.
Regional Market Leadership
North America is anticipated to lead the market, attributed to its advanced healthcare infrastructure and high rate of technology integration.
Workflow Integration Trend
A notable trend is the increasing integration of AI medical imaging software directly into existing clinical workflows, enhancing diagnostic efficiency and accuracy.
Market Dynamics
Market Trends
- Increasing integration of AI into existing imaging workflows.
- Growing demand for cloud-based AI medical imaging platforms.
- Focus on explainable AI (XAI) for enhanced clinical trust.
- Rising adoption of AI for personalized treatment planning.
Growth Drivers
- Rising demand for early and accurate disease diagnosis.
- Growing global shortage of skilled radiologists and specialists.
- Continued technological advancements in AI and deep learning.
- Pressing need for improved workflow efficiency in imaging departments.
Restraints
- Stringent regulatory approval processes delay market entry and widespread adoption.
- High implementation costs and complex integration hinder smaller healthcare providers.
- Concerns over data privacy and security slow the adoption of AI solutions.
- Limited clinician trust and resistance to change impede AI software integration.
Opportunities
- Untapped potential for AI in early rare disease diagnosis.
- Developing AI solutions for image analysis across new medical specialties.
- Expansion into emerging economies with evolving healthcare infrastructure.
- Creating AI for predictive analytics and preventative care strategies.
Market Dynamics Framework · 2026–2035
Need Custom Data for This Market?
Get tailored segmentation, deeper competitive intelligence, or region-specific deep dives from our analyst team.
Market Segmentation
| Segment | Sub-segments |
|---|---|
| By Type | Radiology AI SoftwarePathology AI SoftwareCardiology AI SoftwareOphthalmology AI SoftwareOncology AI SoftwareNeurology AI SoftwareOrthopedics AI SoftwareOthers |
| By Application | Disease Detection and DiagnosisPrognosis and Risk AssessmentTreatment Planning and GuidanceImage Analysis and InterpretationWorkflow OptimizationDrug Discovery and DevelopmentEducation and Training |
| By Technology | Deep LearningMachine LearningNatural Language ProcessingComputer VisionPredictive Analytics |
| By End-User | HospitalsDiagnostic Imaging CentersResearch and Academic InstitutionsPharmaceutical and Biotechnology CompaniesAmbulatory Surgical CentersSpecialty Clinics |
| By Deployment | On-PremiseCloud-BasedHybrid |
| By Functionality | Image Segmentation and RegistrationFeature Extraction and QuantificationDiagnosis and Classification AssistanceReporting and Documentation AutomationRisk StratificationImage Acquisition and Reconstruction Enhancement |
Regional Analysis
- North America leads the AI medical imaging software market due to its advanced technological infrastructure, substantial R&D investments, and the strong presence of major market players. High adoption rates and a robust healthcare system further solidify its dominant position globally.
- Asia-Pacific is projected to be the fastest-growing region, driven by escalating healthcare expenditure, a rising burden of chronic diseases, and improving digital infrastructure. Expanding access to advanced diagnostics and a vast patient pool also fuel its rapid market expansion.
- In Europe, an emerging trend involves stringent regulatory frameworks, like the EU AI Act, which are shaping AI medical imaging software adoption. These regulations, while potentially slowing initial market entry, aim to build trust and ensure ethical deployment of AI in healthcare across the region.
| North AmericaXX.X% | EuropeXX.X% | Asia PacificXX.X% | Latin AmericaXX.X% | Middle East & AfricaXX.X% |
North America
XX.X% CAGR
US$ XX.X Mn
XX.X% share
- Leading the market with advanced healthcare infrastructure, significant R&D investment, and rapid adoption of AI solutions for diagnostics.
- Growth is driven by technological innovation and a strong focus on improving patient outcomes and operational efficiency.
Latin America
XX.X% CAGR
US$ XX.X Mn
XX.X% share
- Shows significant potential for AI adoption in medical imaging, driven by improving healthcare access and demand for more efficient diagnostic tools.
- However, growth can be uneven due to varying levels of economic development and healthcare infrastructure.
Europe
XX.X% CAGR
US$ XX.X Mn
XX.X% share
- A mature market with a strong emphasis on digital health transformation and value-based care, though regulatory complexities can vary across countries.
- The region sees steady adoption of AI imaging software, particularly in specialized diagnostics and research.
Asia Pacific
XX.X% CAGR
US$ XX.X Mn
XX.X% share
- Experiencing rapid growth fueled by increasing healthcare expenditure, large patient populations, and government initiatives promoting digital health and medical technology adoption.
- This region is becoming a key market for both development and deployment of AI imaging solutions.
Middle East & Africa
XX.X% CAGR
US$ XX.X Mn
XX.X% share
- Characterized by diverse adoption rates, with significant investments in advanced healthcare technologies in wealthier Gulf nations, while other areas face infrastructure limitations.
- The region is poised for considerable growth as healthcare modernization efforts continue.
Country Analysis
United States and Brazil represent the largest country-level markets, with growth across the remaining countries shaped by local regulatory, infrastructure, and demand-side factors specific to each geography.
| # | Country | Market Size | CAGR | Key Driver |
|---|---|---|---|---|
| 1 | United States | US$ XX.X Mn | XX.X% | The U.S. leads in AI medical imaging software adoption due to significant R&D investment, a large number of startups, and a well-established healthcare infrastructure driving innovation and rapid integration of advanced diagnostic tools. |
| 2 | Brazil | US$ XX.X Mn | XX.X% | As the largest economy in South America, Brazil's expanding healthcare market and increasing digital transformation initiatives are driving the adoption of AI medical imaging software, especially in major urban centers. |
| 3 | Germany | US$ XX.X Mn | XX.X% | Germany boasts a highly advanced medical device industry and significant investment in AI research, making it a key European market for the development and adoption of AI diagnostic imaging solutions. |
| 4 | China | US$ XX.X Mn | XX.X% | China is a rapidly expanding market due to massive government investments in AI, a large patient population, and aggressive adoption strategies to integrate AI into its vast healthcare system for efficiency and access. |
| 5 | Saudi Arabia | US$ XX.X Mn | XX.X% | Saudi Arabia's Vision 2030 initiatives heavily prioritize healthcare modernization and digital transformation, driving substantial investments in AI medical imaging software to enhance diagnostic capabilities and efficiency. |
Countries Covered (25)
United States, Canada, Mexico, Brazil, Argentina, Rest of Latin America, Germany, United Kingdom, France, Italy, Spain, Russia, Rest of Europe, China, Japan, India, South Korea, Australia, Taiwan, Malaysia, Rest of Asia Pacific, Saudi Arabia, United Arab Emirates, South Africa, Rest of Middle East & Africa
Competitive Landscape
| # | Company | Share | Key Strategy | Key Note | Key Developments | Key Products |
|---|---|---|---|---|---|---|
| 1 | Aidoc | XX.X% | Focus on AI solutions for radiology to prioritize critical cases and improve turnaround times across various pathologies. | — | — | Aidoc AI PlatformaiPACSStroke Suite+1 |
| 2 | Viz.ai | XX.X% | Leverage AI-powered care coordination to accelerate diagnosis and treatment for acute conditions, focusing on real-time communication. | — | — | Viz ICHViz PEViz Aortic+1 |
| 3 | Lunit | XX.X% | Develop AI solutions for precision diagnostics and treatment in cancer, across radiology and pathology. | — | — | Lunit INSIGHT MMGLunit INSIGHT CXRLunit SCOPE IO+1 |
| 4 | Qure.ai | XX.X% | Utilize deep learning to make diagnostics affordable and accessible, particularly for prevalent conditions like lung diseases and head trauma. | — | — | Qure.ai qXRQure.ai qERQure.ai qSpot-TB+1 |
| 5 | PathAI | XX.X% | Advance precision medicine through AI-powered pathology analysis, focusing on drug development and clinical diagnostics. | — | — | PathAI PlatformAISightTumor microenvironment analysis+1 |
Market Positioning Map
Market share vs. growth outlook — bubble size is market share, bubble color is relative profitability
Companies Profiled (20)
Aidoc, Viz.ai, Lunit, Qure.ai, PathAI, PAIGE, Nanox AI, Brainomix, HeartFlow, Arterys, Volpara Health Technologies, Riverain Technologies, Quantib, VUNO, Sectra, Hologic, InferVision, Blackford Analysis, ContextVision, Agfa HealthCare
The global AI Medical Imaging Software market features a competitive landscape led by Aidoc, Viz.ai, Lunit, Qure.ai, PathAI, and PAIGE, among other established and emerging players. Market participants continue to compete on product innovation, pricing strategy, geographic expansion, and strategic partnerships to strengthen their position in this evolving market.
* Market share estimates based on company revenue disclosures and public sources; undisclosed figures are marked.
Company Profiles
Aidoc
Viz.ai
Lunit
Qure.ai
PathAI
PAIGE
Nanox AI
Brainomix
HeartFlow
Arterys
Volpara Health Technologies
Riverain Technologies
Quantib
VUNO
Sectra
Hologic
InferVision
Blackford Analysis
ContextVision
Agfa HealthCare
* Classification reflects relative market share and maturity, derived from revenue analysis and public disclosures.
Ready to Make Data-Driven Decisions?
Purchase the full report or request a custom engagement. Get analyst support, scenario modelling, and real-time dashboard access.
Recent Market Developments
GE HealthCare Unveils AI-Powered Cardiovascular Imaging Software
GE HealthCare recently launched its new AI solution, CardioSense Pro, designed to automate cardiac MRI analysis and identify early signs of heart disease. This FDA-cleared software, announced in January, significantly reduces reading times and aims to improve diagnostic accuracy.
Philips Acquires NeuroAI Tech to Bolster Diagnostics Portfolio
In a strategic move late last year, Philips acquired NeuroAI Tech, a leading developer of AI solutions for neurological disorder diagnosis. This acquisition integrates NeuroAI's advanced algorithms for brain scans into Philips' imaging platforms, enhancing capabilities in early disease detection.
Aidoc Forges Major Partnership with Mayo Clinic for Enterprise AI Deployment
Aidoc announced a significant multi-year partnership with Mayo Clinic in late 2024 to integrate its comprehensive AI platform across Mayo Clinic's imaging departments. This collaboration aims to enhance diagnostic efficiency, improve workflow for radiologists, and accelerate patient care.
QuantImaging AI Secures US$ XX.X Series D Funding for Global Expansion
Last month, QuantImaging AI closed a substantial US$ XX.X Series D funding round led by major healthcare investment firms. The capital will fuel further R&D into new AI diagnostic applications and support its market expansion into Europe and Asia.
Report Data Parameters
| Parameter | Value |
|---|---|
| Base Year | 2025 |
| Forecast Year | 2035 |
| Historical Period | 2019–2025 |
| Market Size (Base Year) | $2.7 Bn |
| Market Size (Forecast) | $12.4 Bn |
| CAGR | 16.5% |
| Forecast Period | 2026–2035 |
| Geography | Global |
| Countries Covered | 25 Countries |
| Segments Covered | 6 Segments, 35 Sub-segments |
| Companies Profiled | 32 Companies |
Report Value
Why Choose This Report
Complete Market Size
Market sizing for the base year and a 10-year forecast across three scenarios.
Segment Analysis
Deep-dive segmentation by product, application, end-user, and technology verticals.
Country Analysis
Country-level market data for every country in the report scope, across all major regions.
Company Profiles
Profiles of the leading companies, with disclosed financials, strategy and market share.
Market Share
Detailed competitive market share analysis with trend mapping and benchmarking.
Competitive Intelligence
SWOT, Porter's Five Forces, and competitive positioning across market leaders.
Scenario Analysis
Three-scenario modelling (Base / Optimistic / Conservative) with CAGR decomposition.
Regulatory Review
Regulatory landscape, compliance requirements, and policy impact analysis by region.
Strategic Analysis · Management Insights · CXO Insights
Executive Strategic & Intelligence Report
A board-ready strategic deck built on the AI Medical Imaging Software Market report: eleven chapters and an appendix, from market sizing to the board decisions, delivered as a PDF with an Excel datapack. US$3,000 per market, prepared after your order.
What to expect in the Executive Report for this market
- About 400 slides, 11 chapters and an appendix. Built on this report's own numbers, so every figure matches the report and the Excel.
- Market size and forecast to 2035. By segment, sub-segment, region and country, with conservative, base and optimistic cases.
- An analysis page after every exhibit. The key insight, ten specific points and the decision it implies for leaders, challengers, entrants and investors.
- Competitive intelligence. Shares and positioning, capability benchmark, strategies, recent moves and acquisition screening.
- Customers, technology and business models. Who buys and why, AI and technology impact, pricing, channels and go-to-market by segment.
- Risks and scenarios. Risk register, four future scenarios with signposts, and early-warning indicators with thresholds.
- Opportunities and the board decisions. Opportunity scoring, strategic options, roadmap, capability gaps, decision matrix and a 90-day plan.
- PDF, Excel datapack and PowerPoint. A bookmarked PDF, the full Excel datapack and editable infographic slides for your own decks.
US$3,000 per market · bought online, prepared after your order and emailed to you
See a full example report →Only need the headline view? Market Snapshot (PDF) + Excel Datasheet · 10–20 slide PDF + Excel
A CEO-level executive summary of the market in 10–20 slides - size and forecast, growth by segment and region, the leading countries and companies, key trends and the outlook - plus the Excel datasheet. A short executive view of this market, not the full analysis - PDF and Excel, prepared and emailed to you after your order.
Trusted by strategy teams, investors & global enterprises
What Our Clients Say
Verified reviews from enterprise clients
“The depth of analysis and quality of data is unparalleled. This report directly informed our $50M market expansion strategy and helped us prioritise the right geographies.”
VP, Corporate Strategy
Industrial manufacturing company
“Exceptional research quality. The competitive landscape section alone saved our team months of primary research effort and gave us a clear view of the opportunity.”
Director, Investment Research
Private equity firm
“We now use these reports in every planning cycle. The regional granularity, and the same numbers across the report, the dashboard and the Excel, save our team real time.”
Head of Market Intelligence
Specialty chemicals company
Frequently Asked Questions
Common questions about this report and our research
The AI Medical Imaging Software market is estimated at $2.7 Bn in 2025. This figure reflects the current valuation of software solutions leveraging artificial intelligence for medical image analysis across various healthcare settings.
The AI Medical Imaging Software market is forecast to reach $12.4 Bn in 2035, growing at a CAGR of 16.5% from 2025 to 2035. This growth is driven by increasing demand for diagnostic accuracy and workflow efficiency.
The main segments include Type (e.g., Radiology AI Software, Pathology AI Software), Application (e.g., Disease Detection and Diagnosis, Treatment Planning), Technology (e.g., Deep Learning, Machine Learning), End-User (e.g., Hospitals, Diagnostic Imaging Centers), Deployment (e.g., On-Premise, Cloud-Based), and Functionality (e.g., Image Segmentation, Diagnosis Assistance).
Leading companies in this market include Aidoc, Viz.ai, Lunit, Qure.ai, PathAI, PAIGE, Nanox AI, Brainomix, HeartFlow, Arterys, Volpara Health Technologies, and Riverain Technologies. These companies offer various AI-powered solutions for medical image analysis.
The report covers market size and growth forecasts, detailed segmentation by type, application, technology, end-user, deployment, and functionality, and regional analysis. It also includes insights into market drivers, restraints, and profiles of leading companies in the AI Medical Imaging Software market.
The Single User and Enterprise licences include the full PDF report, the PowerPoint (PPT), the Excel data workbook and the interactive Online Dashboard. The Online Dashboard gives online access to the snapshot and datasheet with export features, and the Market Snapshot is an executive summary in PDF with the Excel data sheet.
Yes. Request a free report preview: its scope, every chapter and what it contains, the methodology and the headline figures. The full report is a paid product.
We accept credit/debit cards (Visa, Mastercard, Amex), bank wire transfer, and purchase orders for enterprise clients. All transactions are secured with 256-bit SSL encryption.
Buy This Report
Choose the format that fits your budget
Digital delivery — all sales are final. See our Refund Policy and Terms & Conditions.
Strategic deck for this market
Executive Strategic & Intelligence Report
About 400 board-ready slides: every exhibit with its analysis and the decision it implies. Prepared for this market after your order and emailed to you.
Need to go deeper?
Intelligence services for this market
- Competitor benchmarking →
- Market entry & expansion →
- Product & growth opportunities →
- Investment & acquisition due diligence →
What's Included
Similar Reports
AI Medical Imaging Market
$3.3 Bn in 2025 · 16.8% CAGR
Future Medical Imaging Market
$52.4 Bn in 2025 · 5.9% CAGR
Medical Imaging Informatics Market
$5.7 Bn in 2025 · 7.8% CAGR
AI Imaging Diagnostics Market
$3.8 Bn in 2025 · 17.2% CAGR
AI Medical Device Analytics Market
$2.5 Bn in 2025 · 16.0% CAGR
AI Medical Manufacturing Analytics Market
$600.0 Mn in 2025 · 17.8% CAGR
Clinical AI Imaging Platform Market
$1.5 Bn in 2025 · 22.6% CAGR
Clinical Imaging Intelligence Platform Market
$1.3 Bn in 2025 · 21.7% CAGR